Weighted Average Number of Shares Outstanding, Basic of Cogent Biosciences, Inc. from 31 Mar 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Cogent Biosciences, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Mar 2018 to 31 Dec 2025.
  • Cogent Biosciences, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 128,899,408, a 24% increase year-over-year.
  • Cogent Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 128,899,408, a 24% increase from 2024.
  • Cogent Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 103,856,611, a 30% increase from 2023.
  • Cogent Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 79,657,942, a 36% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Cogent Biosciences, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 128,899,408 +25,042,797 +24% 01 Oct 2025 31 Dec 2025 10-K 17 Feb 2026 2025 FY
Q3 2025 137,550,159 +27,384,579 +25% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 114,466,080 +15,226,050 +15% 01 Apr 2025 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 113,307,940 +18,503,281 +20% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 103,856,611 +24,198,669 +30% 01 Oct 2024 31 Dec 2024 10-K 17 Feb 2026 2025 FY
Q3 2024 110,165,580 +23,999,629 +28% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025 2025 Q3
Q2 2024 99,240,030 +24,486,761 +33% 01 Apr 2024 30 Jun 2024 10-Q 05 Aug 2025 2025 Q2
Q1 2024 94,804,659 +24,069,709 +34% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q4 2023 79,657,942 +20,918,229 +36% 01 Oct 2023 31 Dec 2023 10-K 17 Feb 2026 2025 FY
Q3 2023 86,165,951 +16,589,592 +24% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 74,753,269 +25,364,333 +51% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 70,734,950 +25,629,027 +57% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q4 2022 58,739,713 01 Oct 2022 31 Dec 2022 10-K 25 Feb 2025 2024 FY
Q3 2022 69,576,359 +29,727,416 +75% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 49,388,936 +10,947,207 +28% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 45,105,923 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q3 2021 39,848,943 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 38,441,729 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q4 2019 30,663,054,000 +644,712,000 +2.1% 01 Oct 2019 31 Dec 2019 10-K 26 Mar 2020 2019 FY
Q3 2019 30,661,125,000 +781,649,000 +2.6% 01 Jul 2019 30 Sep 2019 10-K 26 Mar 2020 2019 FY
Q2 2019 30,505,773,000 +1,349,983,000 +4.6% 01 Apr 2019 30 Jun 2019 10-K 26 Mar 2020 2019 FY
Q1 2019 30,083,006,000 +19,878,415,000 +195% 01 Jan 2019 31 Mar 2019 10-K 26 Mar 2020 2019 FY
Q4 2018 30,018,342,000 01 Oct 2018 31 Dec 2018 10-K 26 Mar 2020 2019 FY
Q3 2018 29,879,476,000 01 Jul 2018 30 Sep 2018 10-K 26 Mar 2020 2019 FY
Q2 2018 29,155,790,000 01 Apr 2018 30 Jun 2018 10-K 26 Mar 2020 2019 FY
Q1 2018 10,204,591,000 01 Jan 2018 31 Mar 2018 10-K 26 Mar 2020 2019 FY

Cogent Biosciences, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 128,899,408 +25,042,797 +24% 01 Jan 2025 31 Dec 2025 10-K 17 Feb 2026 2025 FY
2024 103,856,611 +24,198,669 +30% 01 Jan 2024 31 Dec 2024 10-K 17 Feb 2026 2025 FY
2023 79,657,942 +20,918,229 +36% 01 Jan 2023 31 Dec 2023 10-K 17 Feb 2026 2025 FY
2022 58,739,713 +20,008,900 +52% 01 Jan 2022 31 Dec 2022 10-K 25 Feb 2025 2024 FY
2021 38,730,813 01 Jan 2021 31 Dec 2021 10-K 26 Feb 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.